MDS names West COOand CEO to be
Life sciences product devloper MDS has appointed Steve West, president of medical isotope developer MDS Nordion, as its chief operating officer (COO).
According to MDS, Stephen DeFalco, president and CEO of the company, is stepping down from his position. Once the "company is focused solely on the MDS Nordion business," West will become MDS' CEO, the firm stated.
West became president of MDS Nordion in 2003. He began his career at MDS in 2001 as a senior partner with MDS Capital. Prior to that, he was president of DiverseyLever Canada and has held a variety of CEO assignments, as well as international business development responsibilities, in the specialty chemicals field.
According to MDS, Stephen DeFalco, president and CEO of the company, is stepping down from his position. Once the "company is focused solely on the MDS Nordion business," West will become MDS' CEO, the firm stated.
West became president of MDS Nordion in 2003. He began his career at MDS in 2001 as a senior partner with MDS Capital. Prior to that, he was president of DiverseyLever Canada and has held a variety of CEO assignments, as well as international business development responsibilities, in the specialty chemicals field.